The Nephropathy Solution (NES) of Sophia Genetics covers the coding regions (± 5 bp of the intron regions) of 44 most clinically relevant genes related to a broad range of nephropathies such as nephrotic syndromes, polycystic kidney diseases, Bartter syndromes, Alport syndrome, CAKUT or tubulopathies.

It also allows the detection of SNV and Indels, and guarantees a high percentage of readings in the target and uniformity of coverage, even in regions rich in GC.

The kit uses NGS capture technology and is intended for use on Illumina platforms. The results are interpreted in the SOPHiA DDM platform, designed for the analysis and protection of NGS clinical data in routine diagnosis.

SOPHiA DDM analyzes complex NGS genomic data through the detection, annotation and pre-classification of genomic variants to help clinicians better diagnose their patients.

sophia nefro general
Nephropathy Solution (NES) 6

In addition to the Nephropathy Solution, we have other more specific panels for clinical diagnosis in areas such as metabolism, oncology, cardiology…


Area:

Molecular Genetics, Nephropathies, Targeted study of specific pathologies
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Genvinset® deltaF508

Genvinset® deltaF508 is a semi‑automated in vitro diagnostic kit for the qualitative detection of wild‑type and/or F508del alleles of the CFTR gene, associated with cystic fibrosis. The assay is performed on genomic DNA extracted from whole blood using real‑time PCR with TaqMan® probes. Detailed description Key features Genvinset® deltaF508 is designed for the molecular determination…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)

Emedgene

Emedgene™ software is designed to optimise variant interpretation in rare diseases and other germline applications. It combines explainable artificial intelligence, automation and configurable workflows to reduce the variant curation burden and accelerate tertiary analysis. Detailed description Key features It is a comprehensive solution developed to streamline genetic interpretation workflows and reduce the manual effort associated…
Illumina

Devyser LynchFAP

Devyser LynchFAP is a targeted NGS solution for the analysis of germline variants associated with hereditary colorectal cancer syndromes. The assay enables the detection of SNVs, indels, and CNVs in genes related to Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), also incorporating a specific LR-PCR for the correct localization of variants in…
Devyser
Next Generation Sequencing (NGS)

Devyser HBOC NGS

Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron…
Devyser
Next Generation Sequencing (NGS)